Institutional investors hold a majority ownership of ACT through the 92.12% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2015, these large investors purchased a net $223.0 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JANUS CAPITAL MANAGEMENT LLC Bought 2.9 Million shares of Actavis
T. ROWE PRICE ASSOCIATES, INC. Bought 2.4 Million shares of Actavis
WELLINGTON MANAGEMENT CO. LLP Bought 2.2 Million shares of Actavis